p21活化激酶5在骨肉瘤组织中的表达及临床意义

田聪; 汤丽娜; 林峰; 沈赞; 陈杰; 姚阳; 闵大六

doi:10.3969/j.issn.1007-3969.2014.01.001

您当前的位置：

首页 >

文章列表页 >

p21活化激酶5在骨肉瘤组织中的表达及临床意义

更新时间：2025-12-31

- p21活化激酶5在骨肉瘤组织中的表达及临床意义
- Expression and clinical significance of PAK5 protein expression in osteosarcoma
- 中国癌症杂志 2014年24卷第1期页码：1-7
- 作者机构：
  
  1. 苏州大学医学部研究生院,江苏,苏州,215131
  2. 上海交通大学附属第六人民医院肿瘤内科,上海,200233
  3. 上海交通大学附属第六人民医院病理科,上海,200233
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上项目资助(No：81172548)
- DOI：10.3969/j.issn.1007-3969.2014.01.001
  中图分类号：
- 网络出版：2014-02-14，
  
  纸质出版：2014-02-14
- 稿件说明：
移动端阅览
田聪,汤丽娜,林峰,沈赞,陈杰,姚阳,闵大六. p21活化激酶5在骨肉瘤组织中的表达及临床意义[J]. 中国癌症杂志, 2014, 24(1): 1-7.

田聪, 汤丽娜, 林峰, et al. Expression and clinical significance of PAK5 protein expression in osteosarcoma[J]. China Oncology, 2014, 24(1): 1-7.
田聪,汤丽娜,林峰,沈赞,陈杰,姚阳,闵大六. p21活化激酶5在骨肉瘤组织中的表达及临床意义[J]. 中国癌症杂志, 2014, 24(1): 1-7. DOI： 10.3969/j.issn.1007-3969.2014.01.001.

田聪, 汤丽娜, 林峰, et al. Expression and clinical significance of PAK5 protein expression in osteosarcoma[J]. China Oncology, 2014, 24(1): 1-7. DOI： 10.3969/j.issn.1007-3969.2014.01.001.

摘要

背景与目的：p21活化激酶5(p21-activated kinase 5，PAK5)为PAKs家族中新近发现的成员，在细胞骨架重组，细胞生长、增殖、分化，基因转录及细胞凋亡等一系列的细胞功能中发挥重要作用。近来有研究发现PAK5参与了胃癌、肠癌等恶性肿瘤的发生发展过程。本研究旨在探讨PAK5在人骨肉瘤组织中的表达及其与骨肉瘤患者预后的关系。方法：应用免疫组化方法检测92例骨肉瘤活检样本石蜡组织中PAK5蛋白的表达，33例骨巨细胞瘤样本作为阴性对照，并分析PAK5表达与骨肉瘤患者临床参数及生存之间的关系。结果：骨肉瘤组织中PAK5蛋白表达阳性率为71.7%(66/92)，骨巨细胞瘤中未见PAK5表达(0/33)。PAK5表达与患者的性别、年龄、肿瘤部位、肿瘤大小、组织学类型、局部复发等无关，而与Enneking分期、肿瘤坏死率和肺转移相关，且PAK5高表达能降低化疗的有效率。单因素分析表明，肿瘤大小、Enneking分期、局部复发、肺转移及PAK5表达水平是影响骨肉瘤患者预后的因素。多因素分析显示，PAK5表达水平(P=0.001)及肺转移(P=0.015)是影响骨肉瘤预后相关的独立的重要因素。结论：PAK5表达水平与Enneking分期、肿瘤坏死率和肺转移相关；PAK5的表达可作为骨肉瘤预后预测的指标；PAK5高表达能降低化疗的有效率。

Abstract

Background and purpose: p21-activated kinase 5 (PAK5) is a recently identified member of PAKs that regulate many intracellular processes such as cytoskeleton remodeling

cell proliferation

cell differentiation

gene transcription and cell apoptosis. Recently

studies found that PAK5 was overexpressed in some cancer such as gastric and colon cancer. However

the expression status and biological function of PAK5 in osteosarcoma are not clearly known. The objective of this study was to investigate the expression of PAK5 in osteosarcoma tissue and their relationships with the prognosis of osteosarcoma. Methods: The expression of PAK5 was detected by using immunohistochemical method in 92 specimens of human osteosarcoma tissues and 33 cases of osteoclastoma tissue

respectively. Results: The positive rate of PAK5 was 71.7% (66/92) in all the 92 cases of osteosarcoma. PAK5 expressions were not related to clinical variables such as gender

age

tumor location

tumor size

histological type and local recurrence

but significantly related to Enneking grade

tumor cell necrosis rate and lung metastasis

and the high expression of PAK5 may reduce the efficiency of chemotherapy. Survival analysis indicated that high expression of PAK5 correlated with poor prognosis of patients with osteosarcoma. Univariate survival analysis showed that the significant prognostic factors were tumor size

Enneking grade

local recurrence

lung metastasis and expression levels of PAK5. COX multivariate regression identified that the PAK5 expression levels (P=0.001) and lung metastasis (P=0.015) were independent prognostic factors of patients with osteosarcoma. Conclusion: The positive expressions of PAK5 closely correlate with Enneking grade

tumor cell necrosis rate and lung metastasis. Detection of PAK5 may be used as a molecular marker for prognosis of osteosarcoma. The high expression of PAK5 may reduce the efficiency of chemotherapy.

关键词

Keywords

references

浏览量

1451

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

儿童青少年甲状腺髓样癌临床病理学特征及预后分析

胆碱激酶α在不同级别胶质瘤中的表达差异及临床意义

CCL2在骨肉瘤组织中的表达及其临床意义

E R阳性乳腺癌中FGFR1蛋白的表达与ER及预后的关系

共刺激分子B7-H3在骨肉瘤组织中的表达及临床意义